Affirm XL Dietary Supplement re-launched in US
The product, which was produced in Korea, was recalled three years ago, when the new management discovered that the supplement included, and did not list, Sildenafil on the
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
The findings showed that small inhaled doses yielding high peak, short duration lung pirfenidone concentrations provide statistically greater anti-fibrotic efficacy than higher oral doses resulting in low peak
Offering outsourced laboratory services like analysis of biological samples, BioAgilytix serves the pharmaceutical, biotechnology, and agriculture industries which support drug discovery, pre-clinical and clinical development, and manufacturing. BioAgilytix